HD-CL-005 · Medication Administration (UPDATED)

Medication Administration in the Hemodialysis Unit

Policy HD-CL-005 · Hemodialysis Unit

Effective June 25, 2026 Review June 25, 2027 Replaces all previous

1 Purpose

To ensure safe, accurate, and timely administration of medications during hemodialysis, including routine dialysis-related medications, emergency drugs, and antibiotics, while preventing medication errors, infections, and adverse drug events per MOH-Jordan, KDOQI, and ISMP standards.

2 Scope

Applies to all registered nurses and physicians who prescribe, prepare, or administer medications to hemodialysis patients. Dialysis technicians may NOT administer any medication except normal saline flush per protocol.

3 Definitions

MAR Medication Administration Record 5 Rights patient, drug, dose, route, time ESA erythropoiesis-stimulating agent High-Alert heparin, insulin, ESA, IV iron, antibiotics CVC Hub Scrub 15-second alcohol scrub

4 Policy Statement UPDATED

Update 1.1 High-alert & aseptic practice

High-alert meds require double-check. Aseptic technique mandatory. Errors reported within 24h.

Expanded: • Independent double-check includes verification of renal dose adjustments. • Two-patient identifiers (name + MRN/DOB) required. • Aseptic technique explicitly includes vial stopper disinfection (15 sec) and new needle/syringe for each preparation.

Rationale: ISMP 2024 emphasizes double-check with dose verification; vial stopper disinfection reduces contamination risk.

Update 1.2 ESA & IV iron safety

ESA: hold if Hb >11.5 or BP >180/100. IV iron: test dose 25mg, monitor for reaction.

ESA: hold if Hb >11.5, any BP >180/100, or recent hospitalization for MI/stroke. IV Iron: test dose required for all new patients; epinephrine must be at bedside during administration. Hold if active infection or ferritin >800.

Rationale: KDOQI 2012 and Jordan FDA 2022 emphasize infection and iron overload risks with IV iron.

5 Procedure UPDATED

A. General Medication Administration

Order Verification: Check MAR for drug, dose, route, frequency, indication, dialysis day vs non-dialysis day. Clarify with MD if dose not adjusted for HD.

3 Checks: (1) when removing from storage, (2) when preparing/drawing up, (3) at bedside before giving.

5 Rights + 2 Identifiers: Right patient, drug, dose, route, time + Name + MRN/DOB.

Aseptic Technique: Hand hygiene. Disinfect vial stopper with alcohol 15 sec. Use new needle/syringe. For CVC: scrub hub 15 sec, dry 15 sec.

Documentation: Sign MAR immediately after giving. Include time, dose, route, site, response.

B. Routine Dialysis Medications UPDATED

Update 2.1 Expanded medication protocols

Heparin, ESA, IV Iron, Vitamin D, Antibiotics with basic parameters.

Enhanced protocols: • Heparin: hold if platelets <50k, active bleeding, or pre-op; protamine reversal dose added. • ESA: hold parameters for Hb >11.5, BP >180/100, recent MI/stroke. • IV Iron: test dose details, epinephrine at bedside, hold for active infection or ferritin >800. • Antibiotics: give after HD unless ordered otherwise; trough levels for vancomycin.

Rationale: Detailed hold parameters and safety checks reduce adverse events; post-HD antibiotic timing preserves dialysis efficacy.

Medication	Indication	Timing	Dose Range	Route	Key Safety Points
Heparin	Anticoagulation	Loading: start; hourly via pump	Load 1000-5000u; hourly 500-2000u/hr	IV via machine port/CVC	Double-check. Hold if platelets <50k, active bleed, pre-op. Protamine 1mg/100u.
ESA (Epogen/Aranesp)	Anemia (Hb <10)	1-3x/week; last 30-60min HD	Per protocol	IV preferred; SC if no IV	Double-check. Hold if Hb >11.5, BP >180/100, recent MI/stroke. Do not shake.
IV Iron (Iron sucrose)	Iron deficiency (TSAT <30%, Ferritin <500)	Weekly-monthly; test dose 1st time	100mg over 5min or 200mg over 15min	IV via venous line	Test dose 25mg over 5min. Epinephrine at bedside. Hold if active infection or ferritin >800.
Vitamin D (Calcitriol)	SHPT (PTH >300)	1-3x/week post-HD	Per protocol	IV	Monitor Ca/Phos. Hold if Ca >10.2 or Phos >5.5.
Antibiotics (Vancomycin, Ceftazidime)	Infection/CRBSI	Per culture; usually post-HD	Loading + maintenance	IV via CVC or AVF	Give AFTER HD unless ordered. Trough levels. Antibiotic lock if ordered.

C. High-Alert Medication Double-Check Process UPDATED

Update 2.2 Independent double-check protocol

RN #1 prepares, RN #2 verifies patient/drug/dose/route/time. Both sign.

Required for: Heparin, ESA, IV Iron, Insulin, Antibiotics, any IV push >10mL, and any medication requiring renal dose adjustment. Verification includes expiry date, concentration, and renal dose appropriateness. If discrepancy, do not give; clarify with MD/pharmacy.

Rationale: Expanding double-check to include renal dose adjustment reduces errors in this high-risk population.

High-Alert Meds: Heparin · ESA · IV Iron · Insulin · Antibiotics · Any IV push >10mL · Renal-dose-adjusted medications

Process: RN #1 prepares, RN #2 independently verifies. Both sign MAR or High-Alert Med Log HD-CL-005-F1.

D. CVC Medication Administration – Infection Critical

Mandatory: Scrub hub 15 sec with alcohol pad before each connection. Use new sterile cap after disconnection.

Antibiotic Lock Protocol: Vancomycin 5mg/mL + Heparin 100u/mL OR Taurolidine. Volume = catheter volume + 0.1mL. Dwell until next HD.

Do Not Use CVC if Exit Score ≥2 or purulent drainage. Obtain peripheral IV or IM order.

E. Emergency Medications – Crash Cart UPDATED

Update 2.3 Emergency protocols & Air embolism

Code Blue, Anaphylaxis, Hyperkalemia, Air Embolism, Protamine.

Added detail: • Air embolism protocol: place left lateral Trendelenburg, 100% O₂, clamp lines, call code. • Protamine dosing: 1mg/100u heparin, max 50mg, give slow IV over 10min. • Anaphylaxis: stop IV iron/ESA immediately, epinephrine 0.3mg IM, D50, Solumedrol, Diphenhydramine.

Rationale: Air embolism is a rare but fatal HD complication; explicit protocol improves response. Protamine dosing clarity prevents overdose.

Code Blue: Epinephrine, Atropine, Amiodarone, D50, Calcium, Sodium bicarb. ACLS protocols.

Anaphylaxis: Epinephrine 0.3mg IM, D50, Solumedrol, Diphenhydramine. Stop IV iron/ESA immediately.

Hyperkalemia (K >6.5): Calcium gluconate, D50+Insulin, Albuterol neb, Kayexalate. Dialyze stat.

Air Embolism: Left lateral Trendelenburg, 100% O₂, clamp lines, call code.

Protamine: 1mg reverses 100 units heparin. Max 50mg. Slow IV over 10min.

F. Medication Errors & Adverse Reactions

If Error Occurs: Assess patient immediately. Notify MD + in-charge RN now. Complete incident report within 24h. Do not conceal.

If ADR Occurs: Stop drug. Maintain IV access. Treat symptoms: O₂, Benadryl, epinephrine per protocol. Document reaction in chart + allergy list. Report to MOH Pharmacovigilance if serious.

G. Storage & Handling UPDATED

Update 2.4 ESA/iron storage & narcotic count

Med room locked, temp 15-25°C, fridge 2-8°C. ESA/iron protect from light. Heparin vials discard after 28 days. Narcotics double-locked.

Add: • ESA/iron must be protected from light; single-use vials discarded immediately after entry. • Narcotic count performed each shift by 2 RNs, documented on Controlled Substance Log. • Fridge temperature log maintained daily with action if out of range.

Rationale: Single-use vial discarding prevents contamination; narcotic count compliance is a regulatory requirement.

7 Staff Competency UPDATED

Update 3.1 Remediation & ESA/iron competency

Initial: written med calculation test 90% + 3 observed IV pushes + high-alert demo. Annual: med error quiz + observed CVC admin. ESA/iron separate competency.

Initial: written med calculation test 90% pass + 3 observed IV pushes + high-alert double-check demo. ESA/iron competency requires verbalization of hold parameters (Hb, BP, infection, ferritin). If medication error occurs: remediation required; RN cannot give high-alert meds until re-validated by in-charge.

Rationale: Remediation after errors prevents recurrence; ESA/iron hold parameters are critical for patient safety.

8 Quality Monitoring – QAPI Indicators UPDATED

Update 4.1 New & refined quality metrics

Med error rate <5; double-check compliance 100%; hub scrub 100%; ESA hold compliance 100%; anaphylaxis 0; antibiotic timing >90%.

Add: • % of patients with ESA held appropriately for Hb >11.5, BP >180/100, or recent MI/stroke – target 100% • IV iron test dose completion for new patients – target 100% • High-alert med documentation (double-check signed) – target 100% • Narcotic count discrepancy rate – target 0.

Rationale: Expanded KPIs drive accountability for ESA/iron safety and controlled substance compliance.

9 References UPDATED

Update 5.1 Updated reference list

Ministry of Health – Hashemite Kingdom of Jordan. Standards for Hemodialysis Units, 2023. Section 8: Medication Management.
KDOQI Clinical Practice Guideline for Anemia in CKD: 2012 Update (with 2025 commentary).
ISMP. High-Alert Medications in Acute Care Settings, 2024.
CDC. Safe Injection Practices in Dialysis Settings, 2016.
Jordan FDA. Guidelines for IV Iron Administration, 2022.
MOH-Jordan Medication Error Reporting Guidelines, 2024.

⏺ Summary of key updates

Section	Update	Clinical rationale
4. Policy	High-alert double-check includes renal dose verification; vial stopper disinfection; ESA hold for MI/stroke; IV iron hold for infection/ferritin >800	ISMP 2024; KDOQI 2012; Jordan FDA 2022
5. Procedure (B)	Expanded heparin, ESA, IV iron protocols with detailed hold parameters and safety checks	Detailed parameters reduce adverse events; post-HD antibiotic timing preserves dialysis efficacy
5. Procedure (C)	Double-check expanded to renal-dose-adjusted medications; verification includes expiry, concentration, dose appropriateness	Renal dose adjustment errors are common; expanding double-check reduces risk
5. Procedure (E)	Air embolism explicit protocol; protamine dosing details; anaphylaxis steps	Air embolism is fatal; explicit protocol improves response; protamine clarity prevents overdose
5. Procedure (G)	Single-use vial discarding; narcotic count by 2 RNs; fridge temp log	Prevents contamination; regulatory compliance; ensures medication integrity
7. Competency	Remediation after errors; ESA/iron hold parameters verbalized	Prevents recurrence; critical safety knowledge
8. QAPI	New KPIs: ESA hold compliance, IV iron test dose completion, high-alert documentation, narcotic discrepancies	Drives accountability for ESA/iron safety and controlled substance compliance

Policy HD‑CL‑005 · Proposed updates June 26, 2026 All changes reviewed against MOH‑Jordan 2023, KDOQI 2012, ISMP 2024, and Jordan FDA 2022.

Medication Administration In The Hemodialysis Unit · Version 2026-06-27 · Hemodialysis Unit

📋 Back to All Policies · 🖨️ Print This Page

Aligned with KDOQI, AAMI/ISO, CDC, MOH-Jordan 2023, JCI 8th Ed.